NCT00724919View on ClinicalTrials.gov

A Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, Ecoli

CompletedOBSERVATIONAL
Enrollment

256

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Infection
Trial Locations (2)

351

Miaoli County

40705

Taichung

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00724919 - A Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, Ecoli | Biotech Hunter | Biotech Hunter